Udemy - Coronavirus Story Perception By Using Maram Shtaya Approa...

Files:

• Get Bonus Downloads Here.url (0.2 KB)
~Get Your Files Here ! 1 - Background Literature Review Statement of the Problem & Rational of the Course
• 1 - Background of the Course.mp4 (95.8 MB)
• 1 - Multiple Choice.html (0.0 KB)
• 2 - Background of the Course.html (6.2 KB)
• 2 - Background-of-the-Course-Coronavirus-Story.pdf (142.5 KB)
• 3 - Literature Review.mp4 (19.6 MB)
• 4 - Literature Review.html (6.9 KB)
• 4 - Literature-Review-Coronavirus-Story.pdf (152.5 KB)
• 5 - Statement of the Problem and Rational of the Course.mp4 (20.3 MB)
• 6 - Statement of the Problem and Rational of the Course.html (3.2 KB)
• 6 - Statement-of-the-Problem-and-Rational-of-the-Course-Coronavirus-Story.pdf (85.4 KB)
10 - Acute Respiratory Tract Contagions Pneumonia Hypoxaemia and ARDS
• 10 - Multiple Choice.html (0.0 KB)
• 61 - Acute Respiratory Tract Contagions.mp4 (63.8 MB)
• 62 - Acute Respiratory Tract Contagions.html (4.2 KB)
• 62 - Acute-Respiratory-Tract-Contagions-Coronavirus-Story.pdf (246.2 KB)
• 63 - An Essential Reason of Pneumonia.mp4 (10.5 MB)
• 64 - An Essential Reason of Pneumonia.html (2.7 KB)
• 64 - An-Essential-Reason-of-Pneumonia-Coronavirus-Story.pdf (137.6 KB)
• 65 - Hypoxaemia and Acute Respiratory Distress Syndrome ARDS.mp4 (6.4 MB)
• 66 - Hypoxaemia and Acute Respiratory Distress Syndrome ARDS.html (2.3 KB)
• 66 - Hypoxaemia-and-Acute-Respiratory-Distress-Syndrome-Coronavirus-Story.pdf (127.5 KB)
11 - Coronaviruses CoVs Effects on Humans and Animals and Urbanization Consequences
• 11 - Multiple Choice.html (0.0 KB)
• 67 - Coronaviruses CoVs Effects on Humans and Animals.mp4 (65.9 MB)
• 68 - Coronaviruses CoVs Effects on Humans and Animals.html (4.2 KB)
• 68 - Coronaviruses-Effects-on-Humans-and-Animals-Coronavirus-Story.pdf (131.1 KB)
• 69 - Urbanization Consequences.mp4 (12.5 MB)
• 70 - Urbanization Consequences.html (3.8 KB)
• 70 - Urbanization-Consequences-Coronavirus-Story.pdf (137.8 KB)
12 - Coronavirus Control Procedures and Exposure to Somebody Who has COVID19
• 71 - Coronavirus Control Procedures.mp4 (45.4 MB)
• 72 - Coronavirus Control Procedures.html (2.7 KB)
• 72 - Coronavirus-Control-Procedures-Coronavirus-Story.pdf (136.0 KB)
• 73 - After Exposure to Somebody Who has COVID19.mp4 (13.7 MB)
• 74 - After Exposure to Somebody Who has COVID19.html (3.2 KB)
• 74 - After-Exposure-to-Somebody-Who-has-COVID-19-Coronavirus-Story.pdf (142.5 KB)
13 - COVID19 Disease and Symptoms
• 12 - Multiple Choice.html (0.0 KB)
• 75 - SARS‑CoV‑2 Virus and COVID19 Disease.mp4 (39.8 MB)
• 76 - SARS-CoV-2-Virus-and-COVID-19-Disease-Coronavirus-Story.pdf (152.0 KB)
• 76 - SARS‑CoV‑2 Virus and COVID19 Disease.html (3.0 KB)
• 77 - COVID19 Symptoms.mp4 (15.1 MB)
• 78 - COVID-19-Symptoms-Coronavirus-Story.pdf (244.8 KB)
• 78 - COVID19 Symptoms.html (3.6 KB)
14 - Procalcitonin and Antibody Responses to SARSCoV2
• 13 - Multiple Choice.html (0.0 KB)
• 79 - Procalcitonin A BacteriaParticular Biomarker.mp4 (23.8 MB)
• 80 - Procalcitonin A BacteriaParticular Biomarker.html (1.7 KB)
• 80 - Procalcitonin-Coronavirus-Story.pdf (125.2 KB)
• 81 - Antibody Responses to SARSCoV2 A Pivotal Concern.mp4 (12.1 MB)
• 82 - Antibody Responses to SARSCoV2 A Pivotal Concern.html (3.7 KB)
• 82 - Antibody-Responses-to-SARS-CoV-2-Coronavirus-Story.pdf (129.5 KB)
15 - Suggestions Concerning Health Communication
• 83 - Suggestions Concerning Health Communication.mp4 (12.3 MB)
• 84 - Suggestions Concerning Health Communication.html (2.6 KB)
• 84 - Suggestions-Concerning-Health-Communication-Coronavirus-story.pdf (143.4 KB)
16 - Treatment of Patients with Coronavirus
• 100 - 5 Anticoagulants and COVID19 Biomarkers – Part Two.html (3.2 KB)
• 100 - Anticoagulants-and-COVID-19-Biomarkers-2.pdf (138.9 KB)
• 101 - 6 NSAIDs Usage in Covid19 Patients.mp4 (22.4 MB)
• 102 - 6 NSAIDs Usage in Covid19 Patients.html (1.6 KB)
• 102 - NSAIDs-Usage-in-Covid-19-Patients-Coronavirus-story.pdf (125.3 KB)
• 103 - 7 Bronchodilators Usage in Covid19 Patients.mp4 (4.0 MB)
• 104 - 7 Bronchodilators Usage in Covid19 Patients.html (1.1 KB)
• 104 - Bronchodilators-Usage-in-Covid-19-Patients-Coronavirus-story.pdf (82.9 KB)
• 105 - 8 Gastrointestinal Agents Usage in COVID19 Patients.mp4 (6.4 MB)
• 106 - 8 Gastrointestinal Agents Usage in COVID19 Patients.html (1.6 KB)
• 106 - Gastrointestinal-Agents-Usage-in-COVID-19-Patients-Coronavirus-Story.pdf (125.3 KB)
• 107 - 9 Antihypertensive Drugs Usage in COVID19 Patients.mp4 (5.3 MB)
• 108 - 9 Antihypertensive Drugs Usage in COVID19 Patients.html (2.2 KB)
• 108 - Antihypertensive-Drugs-Usage-in-COVID-19-Patients-Coronavirus-Story.pdf (127.4 KB)
• 14 - Multiple Choice.html (0.0 KB)
• 15 - Multiple Choice.html (0.0 KB)
• 16 - Multiple Choice.html (0.0 KB)
• 85 - Nutrition A Determinant Agent for Homeostasis.mp4 (65.1 MB)
• 86 - Nutrition A Determinant Agent for Homeostasis.html (3.8 KB)
• 86 - Nutrition-Coronavirus-Stroy.pdf (136.4 KB)
• 87 - Some of Probable Therapeutics for Patients with Coronavirus.mp4 (10.3 MB)
• 88 - Some of Probable Therapeutics for Patients with Coronavirus.html (3.9 KB)
• 88 - Some-of-Probable-Therapeutics-for-Patients-with-Coronavirus-Coronavirus-Story.pdf (139.3 KB)
• 89 - Pharmacological Treatment 1 Antimicrobials Usage in Covid19 Patients.mp4 (13.4 MB)
• 90 - Antimicrobials-Usage-in-Covid-19-Coronavirus-Story.pdf (140.4 KB)
• 90 - Pharmacological Treatment 1 Antimicrobials Usage in Covid19 Patients.html (4.5 KB)
• 91 - 2 Corticosteroid Usage in Patients with Coronavirus.mp4 (15.8 MB)
• 92 - 2 Corticosteroid Usage in Patients with Coronavirus.html (4.8 KB)
• 92 - Corticosteroid-Usage-in-Patients-with-Coronavirus-Coronavirus-Story.pdf (140.8 KB)
• 93 - 3 Antimalarial and Antiviral Agents Use in Covid19 Patients.mp4 (9.2 MB)
• 94 - 3 Antimalarial and Antiviral Agents Use in Covid19 Patients.html (2.5 KB)
• 94 - Antimalarial-and-Antiviral-Agents-Use-in-Covid-19-Coronavirus-Story.pdf (127.8 KB)
• 95 - 4 Nacetylcysteine Usage in Covid19 Patients.mp4 (37.0 MB)
• 96 - 4 Nacetylcysteine Usage in Covid19 Patients.html (1.9 KB)
• 96 - N-acetylcysteine-Usage-in-Covid-19-Patients-Coronavirus-Story.pdf (126.0 KB)
• 97 - 5 Anticoagulants and COVID19 Biomarkers – Part One.mp4 (13.1 MB)
• 98 - 5 Anticoagulants and COVID19 Biomarkers – Part One.html (3.5 KB)
• 98 - Anticoagulants-and-COVID-19-Biomarkers.pdf (129.2 KB)
• 99 - 5 Anticoagulants and COVID19 Biomarkers – Part Two.mp4 (11.0 MB)
17 - ECMO Machine Fluid management Spirometer Use and Drug Repurposing
• 109 - ECMO Machine HighFlow Oxygen Fluid management and Spirometer Use.mp4 (78.9 MB)
• 110 - ECMO Machine HighFlow Oxygen Fluid management and Spirometer Use.html (4.6 KB)
• 110 - ECMO-Machine-High-Flow-Oxygen-Fluid-management-and-Spirometer-Use-Coronavirus-Story.pdf (132.7 KB)
• 111 - Drug Repurposing A Prosperous Tactic.mp4 (20.1 MB)
• 112 - Drug Repurposing A Prosperous Tactic.html (4.6 KB)
• 112 - Drug-Repurposing-Coronavirus-Story.pdf (145.7 KB)
• 17 - Multiple Choice.html (0.0 KB)
18 - The COVID19 Vaccine Scheme Improvement and Platforms
• 113 - The COVID19 Vaccine Scheme.mp4 (54.7 MB)
• 114 - The COVID19 Vaccine Scheme.html (2.8 KB)
• 114 - The-COVID-19-Vaccine-Scheme-Coronavirus-Story.pdf (127.8 KB)
• 115 - The Improvement of SARSCoV2 Vaccines.mp4 (19.0 MB)
• 116 - The Improvement of SARSCoV2 Vaccines.html (3.9 KB)
• 116 - The-Improvement-of-SARS-CoV-2-Vaccines-Coronavirus-Story.pdf (134.4 KB)
• 117 - Vaccine Platforms.mp4 (13.5 MB)
• 118 - Vaccine Platforms.html (4.3 KB)
• 118 - Vaccine-Platforms-Coronavirus-Story.pdf (140.1 KB)
• 18 - Multiple Choice.html (0.0 KB)
19 - Conclusion Limitations and Future Perspectives
• 119 - Summary.mp4 (106.8 MB)
• 120 - Summary-Coronavirus-Story.pdf (138.9 KB)
• 120 - Summary.html (4.4 KB)
• 121 - Future Work and Recommendations.mp4 (24.6 MB)
• 122 - Future Work and Recommendations.html (4.8 KB)
• 122 - Future-Work-and-Recommendations-Coronavirus-Story.pdf (88.3 KB)
• 123 - Limitations.mp4 (28.2 MB)
• 124 - Limitations-Coronavirus-Story.pdf (138.8 KB)
• 124 - Limitations.html (5.7 KB)
2 - Objectives of the Course Course Questions and Significance of the Course
• 10 - Course Questions.html (3.9 KB)
• 10 - Course-Questions-Coronavirus-Story.pdf (128.2 KB)
• 11 - Significance of the Course.mp4 (24.8 MB)
• 12 - Significance of the Course.html (5.1 KB)
• 12 - Significance-of-the-Course-Coronavirus-Story.pdf (130.1 KB)
• 2 - Multiple Choice.html (0.0 KB)
• 7 - Objectives of the Course.mp4 (120.5 MB)
• 8 - Objectives of the Course.html (4.5 KB)
• 8 - Objectives-of-the-Course-Coronavirus-Story.pdf (136.2 KB)
• 9 - Course Questions.mp4 (22.6 MB)
20 - Abbreviations Whole Articles Curriculum and Resources of Course Material
• 125 - Abbreviations.mp4 (7.5 MB)
• 126 - Abbreviations-Coronavirus.pdf (85.0 KB)
• 126 - Abbreviations.html (1.7 KB)
• 127 - The Course Articles Part One.mp4 (55.9 MB)
• 128 - The Course Articles Part Two.mp4 (49.0 MB)
• 129 - The Course Articles Part Three.mp4 (48.8 MB)
• 130 - Curriculum of the Course.mp4 (12.2 MB)
• 131 - Resources of Course Material.mp4 (56.0 MB)
• 131 - Resources-Coronavirus-Story-Perception.pdf (350.1 KB)
21 - Bonus Lecture
• 132 - Bonus Lecture with Updated Discount Coupons.html (13.8 KB)
3 - Maram Shtaya Approach and Its Significance
• 13 - Maram Shtaya Approach.mp4 (77.9 MB)
• 14 - Maram Shtaya Approach.html (3.3 KB)
• 14 - Maram-Shtaya-Approach-Coronavirus-Story.pdf (137.7 KB)
• 15 - Significance of Maram Shtaya Approach.mp4 (16.3 MB)
• 16 - Significance of Maram Shtaya Approach.html (3.4 KB)
• 16 - Significance-of-Maram-Shtaya-Approach-Coronavirus-Sory.pdf (128.7 KB)
• 3 - Multiple Choice.html (0.0 KB)
4 - Maram Shtaya Approach is a Combination of the Following Theories
• 17 - 1 Transtheoretical Model TTM.mp4 (48.6 MB)
• 18 - 1 Transtheoretical Model TTM.html (3.2 KB)
• 18 - Transtheoretical-Model-Coronavirus-Story.pdf (137.7 KB)
• 19 - The Four Structures of the TTM.mp4 (16.3 MB)
• 20 - The Four Structures of the TTM.html (3.4 KB)
• 20 - The-Four-Structures-of-the-TTM-Coronavirus-Story.pdf (128.4 KB)
• 21 - 2 Protection Motivation Theory PMT.mp4 (6.1 MB)
• 22 - 2 Protection Motivation Theory PMT.html (1.9 KB)
• 22 - Protection-Motivation-Theory-Coronavirus-Story.pdf (125.4 KB)
• 23 - The Structure of Protection Motivation Theory PMT.mp4 (9.3 MB)
• 24 - The Structure of Protection Motivation Theory PMT.html (2.2 KB)
• 24 - The-Structure-of-Protection-Motivation-Theory-Coronavirus-Story.pdf (167.9 KB)
• 25 - 3 KAP Survey Model.mp4 (24.1 MB)
• 26 - 3 KAP Survey Model.html (1.3 KB)
• 26 - KAP-Survey-Model-Coronavirus-Story.pdf (134.2 KB)
• 27 - 4 Communication Theory.mp4 (7.6 MB)
• 28 - 4 Communication Theory.html (2.8 KB)
• 28 - Communication-Theory-Coronavirus-Story.pdf (134.9 KB)
• 29 - 5 Normalisation Process Theory NPT.mp4 (9.1 MB)
• 30 - 5 Normalisation Process Theory NPT.html (2.3 KB)
• 30 - Normalisation-Process-Theory-Coronavirus-Story.pdf (127.2 KB)
• 31 - The Normalisation Process Theory NPT Prime Elements.mp4 (7.6 MB)
• 32 - The Normalisation Process Theory NPT Prime Elements.html (1.9 KB)
• 32 - The-Normalisation-Process-Theory-Coronavirus-Story.pdf (83.7 KB)
• 33 - 6 Holism Theory.mp4 (9.1 MB)
• 34 - 6 Holism Theory.html (1.8 KB)
• 34 - Holism-Theory-Coronavirus-Story.pdf (125.5 KB)
• 35 - 7 Complexity Theory.mp4 (4.8 MB)
• 36 - 7 Complexity Theory.html (1.7 KB)
• 36 - Complexity-Theory-Coronavirus-Story.pdf (125.0 KB)
• 4 - Multiple Choice.html (0.0 KB)
• 5 - Multiple Choice.html (0.0 KB)
5 - Coronavirus Expression and Genera
• 37 - Coronavirus Expression.mp4 (64.4 MB)
• 38 - Coronavirus Expression.html (3.6 KB)
• 38 - Coronavirus-Expression-Coronavirus-Story.pdf (143.0 KB)
• 39 - The Four Coronavirus Genera.mp4 (10.6 MB)
• 40 - The Four Coronavirus Genera.html (2.7 KB)
• 40 - The-Four-Coronavirus-Genera-Coonavirus-Story.pdf (136.6 KB)
• 6 - Multiple Choice.html (0.0 KB)
6 - SARSCoV and MERSCoV
• 41 - Severe Acute Respiratory Syndrome Coronavirus SARSCoV.mp4 (25.7 MB)
• 42 - Severe Acute Respiratory Syndrome Coronavirus SARSCoV.html (1.9 KB)
• 42 - Severe-Acute-Respiratory-Syndrome-Coronavirus-Coronavirus-Story.pdf (83.8 KB)
• 43 - Middle East Respiratory Syndrome Coronavirus MERSCoV.mp4 (6.2 MB)
• 44 - Middle East Respiratory Syndrome Coronavirus MERSCoV.html (2.1 KB)
• 44 - Middle-East-Respiratory-Syndrome-Coronavirus-Coronavirus-Story.pdf (127.2 KB)
• 7 - Multiple Choice.html (0.0 KB)
7 - The Coronavirus Genome Structure Epidemiologic Realization and Expansion
• 45 - The Coronavirus Genome and Structure.mp4 (7.2 MB)
• 46 - The Coronavirus Genome and Structure.html (1.9 KB)
• 46 - The-Coronavirus-Genome-and-Structure-Coronavirus-Story.pdf (125.4 KB)
• 47 - The Epidemiologic Coronavirus Realization.mp4 (40.7 MB)
• 48 - The Epidemiologic Coronavirus Realization.html (2.4 KB)
• 48 - The-Epidemiologic-Coronavirus-Realization-Coronavirus-Story.pdf (127.5 KB)
• 49 - Coronavirus Expansion A Central Worry.mp4 (13.2 MB)
• 50 - Coronavirus Expansion A Central Worry.html (3.5 KB)
• 50 - Coronavirus-Expansion-Coronavirus-Story.pdf (141.3 KB)
8 - Coronavirus Phylogenetics and Taxonomy
• 51 - Coronavirus Phylogenetics and Taxonomy Alphacoronavirus.mp4 (9.9 MB)
• 52 - Coronavirus Phylogenetics and Taxonomy Alphacoronavirus.html (2.6 KB)
• 52 - Coronavirus-Phylogenetics-and-Taxonomy-Alphacoronavirus-Coronavirus-Story.pdf (127.6 KB)
• 53 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part One.mp4 (9.2 MB)
• 54 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part One.html (2.7 KB)
• 54 - Coronavirus-Phylogenetics-and-Taxonomy-Betacoronavirus-1-Coronavirus-Story.pdf (128.4 KB)
• 55 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part Two.mp4 (13.0 MB)
• 56 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part Two.html (2.9 KB)
• 56 - Coronavirus-Phylogenetics-and-Taxonomy-Betacoronavirus-2-Coronavirus-Story.pdf (170.8 KB)
• 8 - Multiple Choice.html (0.0 KB)
9 - Coronavirus Pathogenesis Receptor Interaction Incorporation and Entrance
• 57 - Coronavirus Pathogenesis.mp4 (56.7 MB)
• 58 - Coronavirus Pathogenesis.html (3.4 KB)
• 58 - Coronavirus-Pathogenesis-Coronavirus-Story.pdf (142.0 KB)
• 59 - Coronavirus Proteins Receptor Interaction Incorporation and Entrance.mp4 (10.4 MB)
• 60 - Coronavirus Proteins Receptor Interaction Incorporation and Entrance.html (3.3 KB)
• 60 - Coronavirus-Proteins-Coronavirus-Story.pdf (128.5 KB)
• 9 - Multiple Choice.html (0.0 KB)
• Bonus Resources.txt (0.4 KB)